Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-56.02 Insider Own61.02% Shs Outstand17.82M Perf Week-8.91%
Market Cap287.97M Forward P/E- EPS next Y-3.53 Insider Trans12.68% Shs Float6.94M Perf Month-25.74%
Income-292.42M PEG- EPS next Q-0.88 Inst Own11.03% Short Float16.63% Perf Quarter-6.48%
Sales25.91M P/S11.11 EPS this Y85.96% Inst Trans74.19% Short Ratio7.53 Perf Half Y-28.39%
Book/sh-21.18 P/B- EPS next Y49.55% ROA-121.61% Short Interest1.15M Perf Year-53.96%
Cash/sh5.80 P/C2.78 EPS next 5Y- ROE-49.79% 52W Range11.66 - 42.60 Perf YTD-21.86%
Dividend Est.- P/FCF- EPS past 5Y10.69% ROI- 52W High-62.07% Beta0.64
Dividend TTM- Quick Ratio3.03 Sales past 5Y230.86% Gross Margin95.10% 52W Low38.53% ATR (14)2.74
Dividend Ex-Date- Current Ratio3.03 EPS Y/Y TTM-1835.62% Oper. Margin-312.99% RSI (14)34.77 Volatility11.13% 14.01%
Employees38 Debt/Eq- Sales Y/Y TTM-68.68% Profit Margin-1128.78% Recom1.33 Target Price42.60
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-147.65% Payout- Rel Volume0.61 Prev Close16.69
Sales Surprise250.39% EPS Surprise-1086.44% Sales Q/Q-1.65% EarningsMay 08 BMO Avg Volume153.23K Price16.16
SMA20-20.15% SMA50-35.01% SMA200-34.16% Trades Volume92,969 Change-3.18%
Date Action Analyst Rating Change Price Target Change
Jul-02-24Downgrade Oppenheimer Outperform → Perform
Jun-04-24Initiated Oppenheimer Outperform $50
May-24-24Initiated Mizuho Buy $40
Apr-23-24Reiterated H.C. Wainwright Buy $2 → $54
Apr-23-24Initiated Leerink Partners Outperform $39
Aug-18-23Downgrade SVB Securities Outperform → Market Perform $1
Jun-14-22Reiterated Needham Buy $6 → $5
Jun-06-22Initiated SVB Leerink Outperform $7
Jun-15-21Initiated BTIG Research Buy $10
Jan-26-21Upgrade Mizuho Neutral → Buy $2.50 → $8
Jul-08-24 04:05PM
Jul-03-24 02:25PM
Jul-02-24 04:08PM
06:31AM Loading…
Jun-06-24 07:05AM
May-23-24 12:12PM
May-22-24 07:00AM
May-13-24 04:30PM
May-10-24 03:12PM
May-08-24 02:52PM
07:00AM Loading…
May-06-24 04:15PM
Apr-25-24 09:55AM
Apr-22-24 04:30PM
Apr-08-24 09:35AM
Apr-04-24 07:30AM
Apr-02-24 05:41PM
Mar-28-24 04:05PM
Mar-14-24 09:35AM
Mar-07-24 11:51PM
Mar-06-24 07:00AM
Mar-05-24 07:05AM
04:05PM Loading…
Feb-05-24 04:05PM
Jan-22-24 09:19AM
Jan-08-24 07:10AM
Nov-13-23 08:05AM
Oct-31-23 04:03PM
Aug-24-23 06:21AM
Aug-17-23 10:20PM
Jul-14-23 07:08AM
Jul-13-23 03:00PM
Jun-03-23 08:20AM
May-31-23 07:00AM
May-09-23 06:06AM
May-04-23 08:45AM
Apr-28-23 04:05PM
Apr-18-23 06:11AM
Mar-27-23 07:07AM
Mar-21-23 11:48AM
Mar-06-23 05:59AM
Mar-03-23 01:24AM
Mar-02-23 09:25AM
Feb-23-23 08:00AM
Feb-07-23 01:51PM
Jan-31-23 01:15PM
Jan-17-23 11:33AM
Jan-12-23 05:39AM
Jan-09-23 08:00AM
Dec-21-22 10:29AM
Dec-14-22 08:00AM
Dec-01-22 05:43AM
Nov-28-22 08:00AM
Nov-09-22 06:36AM
Nov-07-22 08:00AM
Nov-03-22 09:15AM
Oct-27-22 08:00AM
Oct-18-22 06:13AM
Oct-11-22 08:00AM
Oct-10-22 06:10PM
Sep-29-22 08:00AM
Sep-12-22 08:00AM
Sep-06-22 08:00AM
Aug-30-22 06:21AM
Aug-29-22 05:08PM
Aug-12-22 09:30AM
Aug-09-22 10:25AM
Aug-06-22 08:25AM
Aug-04-22 09:05AM
Aug-01-22 08:00AM
Jul-28-22 12:00PM
Jul-19-22 09:19AM
Jul-14-22 09:03AM
Jul-12-22 07:49AM
Jul-06-22 08:00AM
Jun-29-22 07:00AM
Jun-20-22 07:43AM
Jun-14-22 08:59AM
Jun-13-22 07:30AM
Jun-10-22 03:26PM
Jun-06-22 02:47PM
May-19-22 06:00PM
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPRINGER TIMOTHY ADirectorMar 26 '24Option Exercise1.461,970,4432,876,84733,043,849Mar 26 04:32 PM
SPRINGER TIMOTHY ADirectorMar 18 '24Buy0.6019,04411,39831,073,406Mar 20 05:09 PM
SPRINGER TIMOTHY ADirectorMar 18 '24Buy0.61800488104,818Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 15 '24Buy0.59537,500314,54531,054,362Mar 18 05:29 PM
SPRINGER TIMOTHY ADirectorMar 15 '24Buy0.561,200672104,018Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 14 '24Buy0.54648,372351,67730,516,862Mar 18 05:29 PM
SPRINGER TIMOTHY ADirectorMar 14 '24Buy0.532,0001,061102,818Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 13 '24Buy0.583,2001,868100,818Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 12 '24Buy0.611,20073597,618Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 11 '24Buy0.651,20078596,418Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorMar 08 '24Buy0.664,8003,18795,218Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorFeb 07 '24Buy0.662,4001,57590,418Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorFeb 06 '24Buy0.6580052088,018Mar 28 05:11 PM
SPRINGER TIMOTHY ADirectorJan 17 '24Buy0.6980055287,218Mar 28 05:11 PM
Brunn CarstenPresident and CEOSep 25 '23Sale1.062,9323,108783,081Sep 26 06:01 PM
TRABER PETER GChief Medical OfficerSep 25 '23Sale1.06705747451,826Sep 26 06:00 PM